Member Info for Brighty1

The expectancy is almost over in readiness for our ensuing big RNS which is anticipated any day now. If the inhaler persists in proving that it can stop the hasty corrosion phase of the Covid infection in the subsequent set of data, especially those in patients suffering truly deficient breathing complications, this will be take over / licencing time. The sprint to acquire SNG will be just as enormous as last time's RNS rise and will energise the SNG share price to substantial new highs. If it is announced that the SNG nebulizer actually does give THE definitive boost to the immune system in fighting off Covid the share price will frankly rocket and AZ or ANother will be buying SNG. Fingers crossed everyone for a bidding war. Not long to wait now for the next set of results. I bought SNG for 29p and I am still holding. Good luck, Brighty

Agree with you on that. Woeful is the word I would use. The potential for Sareum is huge but the bod are responsible for the lack lustre share performance. Period. If they operated like our rivals our share price would be so much higher. It's not ramping - It's communication. Today is just another example. The SP is tanking again and as I type is currently 0.80p. Why? Because the bod are failing to ignite investor interest and more to the point generate confidence in their ability to deliver. Good luck, Brighty

TOM was 8+p a year ago with an aspiration to develop a plant. Back then they had hardly any cash. That’s all different now - Tom is in a much stronger financial position following their raise and is a much less risky business today at this price than it was at 8p just 1 year ago. You also need to factor in that TOM has a 100% investment in 9 shale leases, of over 15,488 acres in Utah. Now, when you consider that 10,000 bopd compares to approx $430,000 a day they could be generating returns equal to the entire current mcap of TOM every 9-10 days. Proactive Investors ran an excellent research article on this recently. This is why at some stage TOM will be back in the 8-10p range in the next few months. When it happens that is a x 10 multi bag from today. Good luck, Brighty.

https://www.proactiveinvestors.co.uk/companies/news/922129/tomco-energy-analyst-highlights-attractive-economics-of-a-new-oil-sands-separation-technology-922129.html

In keeping with PhilBoro’s positive messaging point it is worth reiterating that Bristol Myers Squibb’s BMS-986165 has been assessed to have a value of $6.7bn, Yes, 6.7 billion. What came out of the presentation for me again last week reading between the lines was that SDC-1801 could be the first TYK2 inhibitor to move in to trials in this arena. As far as we know Pfizer and Bristol Myers Squibb have not declared any proposals yet to pilot their TYK2 inhibitors in COVID-19. This is a big wow moment that TM rather under played on Friday, perhaps to manage our expectations. We obviously need to get a move on but the chance to be at the top table re negotiations is there for all to see. This will hopefully make the 5p to 10p takeover brigade think again. In a nutshell we Sareum shareholders are sitting on a goldmine with a value way over Thoth2’s 28p range. Good luck, Brighty

Boil's tiny Mcap of £4.5million is crazy based on its potential especially when you factor in the "step change in the value of your company" comment in the recent RNS, pasted below. The point that Timor-Leste and Peru projects are underwritten through 2020 and 2021 says to me that things are beginning to become incredibly appealing. We have a very very small mcap of £4.5million. Imagine if the next RNS news is a sale or JV of one or more of the assets we have % holdings in? This could go up 5 or 10 times the current price quite easily.

This is what the CEO said in the recent RNS.

“Now that the shareholding in SundaGas TLS is established, the progress of the Timor-Leste project, which has the potential to make a step-change in the value of your Company. Following the recent Placing, our proposed work programme for 2020 and into 2021 in Timor-Leste, Peru and the UK is funded".

Dyor and good luck, Brighty

We now know that the COVID-19 pandemic has presented N4P with an amazing opportunity to demonstrate how Nuvec® could markedly improve delivery of a possible coronavirus vaccine. The recent phase 2 success communicated in the RNS announcement last week will also have helped the prospect of licensing / collaboration discussions with prospective partners. Confirmation of a deal could be communicated at any time - at which stage the share price will multiply several times. We are in the right share at the right time and don’t forget N4P holders and newbies that this was 30p+ two years ago, without any major news, so with real news this time this is going to zoom. Good luck, Brighty.

There was a line in the small print of the 15th July RNS which read:..."allowing Nigel Theobald, Chief Executive Officer, more time to focus on driving the Company's development programmes and potential commercial collaborations". This is surely code for "Nigel is in negotiations". Last week's news was just the start of Nigel's focus on "commercial collaborations". This is getting very interesting indeed. Good luck. Brighty

Trading volume in BWNG also returning. 1,400 trades by lunchtime today. Wonderful sustained buying going on. Bodes well.
BWNG £1.20p by January 2021
£2.00 by July 2021
£2.50 by January 2022
£5 also a strong possibility in a couple of years.
This is a great time to buy in to an online stock with a bright future.
Good luck, Brighty

BWNG £1.20p by January 2021, £2.00 by July 2021 and £2.50 by January 2022 is my take AND If things pan out as we all expect and hope then this could even go back to its £5 per share days in the next couple of years. N Brown is in the right place at the right time. See N Brown plc's investor website for the full picture. Good luck, Brighty

The wait is nearly over for the data and remember BOIL was x 5 the current price at 0.54 in February of this year. This could hit 0.54 very quickly again before a sustained rise northwards. For newbies 0.54 was pre the fund raising and agreement. The potential here is huge. I would say 0.5 to start with. Good luck, Brighty

The BWNG re-rate back to £2.50+ is powering on as many on here have correctly predicted. Another key point to highlight is what Paul correctly pointed out here back in June. i.e. in 4 years time we will have "no debt with a loan book worth £2 a share, a 900m clothing business, 60m of property, 100m of inventories and intangibles all thrown in for free". It is little wonder that the N Brown share price is starting its rapid re-rate. I recommend everyone who hasn't seen it yet to read the investor slides on the N Brown plc website. This is an impressive management team who have a clear vision of reducing debt and creating significant share holder value moving forward. Bring on 2021. Good luck, Brighty.

I would have thought Lloyds should be looking at someone such as Rupert Keeley CEO of PayPal Europe to replace AHO. We need someone with digital / online running through their veins to take Lloy forward. Good luck, Brighty

As I said earlier today during the webinar i don't think for one minute that Tim is not in the loop re Sierra / 737. He might be constrained from saying more but there has to be communication between ICR and Sierra which Sar will be privvy to. Good luck, Brighty

JAdam spot on. This will be double the current share price in the next 2 months & probably much higher as people realise just how big ODX could be) once "Newsflow Central" kicks in. There are a number of announcements to be made. Follow the money and have patience is the best approach. Good Luck, Brighty

I agree, BWNG should be £1.50-£2 right now on the current numbers, Ian. I've been saying for quite a while now £1.20p by January 2021, with £2.00 by next July. 18-24 months for £2.50. I think this is probably a modest prediction as it could go back to the £5 era in the next couple of years. Good luck, Brighty

"Await with interest", "noted", "Best of our knowledge", TM quite evasive. "we will monitor Sierra statements". Are we really that out of the loop? Surely there must be an ICR middle person working with Sierra that feeds back to Sar.... Brighty

It was over £5 in 2014. With a return to dividends next year BWNG could be THE share to hold over the next 2 years. Good luck, Brighty

This was 10.25p in 2018 and last year went to 6.20p, so very good gains to be had. It needs to hold above 1p - 1.25p first. The difference this time around is that funding is in place and the revenue opportunities look to be be huge. Good luck, Brighty

Today is more about keeping investors on side. You will recall that the Investor Meet IMC service was introduced by Sareum several months ago when there was a high degree of criticism about Sareum's poor Investor Comms and radio silence when dealing with share holders. The Sareum board would be daft to go in to an AGM / EGM scenario later this year without concrete news of a licencing success as there would be high levels of frustration if this was the case. Look at today as phase 1 of a charm offensive to show that they are listening and engaging whilst they - hopefully - conclude one or more deals on our behalf. Good luck, Brighty

I'm hoping we get results with good news re chinook tomorrow. Good luck all TXP investors. Brighty